Hearing impairment and pigmentary disturbance.
Hearing impairment is a variable manifestation of several heritable conditions in which pigmentation of the skin or eyes is abnormal. Some of these disorders are well recognized although uncommon, while others are virtually private syndromes. Practical issues concerning the major conditions of this type are reviewed in this article on a basis of a survey of 4452 profoundly deaf children attending special schools in Southern Africa, together with investigations in affected families. The Waardenburg syndrome (WS), which is the most common deafness-depigmentation disorder, was present in 121 (2.7%) of the 4452 deaf scholars. Further studies in 7 multigeneration affected families confirmed phenotypic variability and indicated a need for internationally agreed diagnostic criteria. In 4 Cape Town families of mixed ancestry the WS-I gene was linked to the 2q37 locus, but in another large kindred no linkage could be demonstrated. Nonallelic heterogeneity is possible. There is uncertainty concerning possible interrelationship between WS and piebaldism. The phenotypic consistency of a South African family in which 7 persons in 3 generations had gross piebaldism in the absence of disturbance of hearing or involvement of the eyes and periorbital structures is suggestive that this disorder and WS are separate entities. Molecular investigations indicate that the gene for piebaldism in this kindred is not situated at the WS-I locus 2q37. Deafness and hyperpigmentation are present in neurofibromatosis type II (acoustic neuromata) and the multiple lentigines syndrome, while retinal pigmentation is a feature of the Usher syndrome. This latter entity is apparently much less common in Southern Africa than in other parts of the world.
Beighton
P
P
Department of Human Genetics, Department of Otolaryngology, University of Cape Town Medical School, South Africa.
Ramesar
R
R
Winship
I
I
Viljoen
D
D
Greenberg
J
J
Young
K
K
Curtis
D
D
Sellars
S
S
D000417:Albinism / Q000235:genetics; D003638:Deafness / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D016518:Neurofibromatosis 2 / Q000235:genetics; D010375:Pedigree; D016116:Piebaldism / Q000235:genetics; D010859:Pigmentation Disorders / Q000235:genetics*; D013577:Syndrome; D014849:Waardenburg Syndrome / Q000235:genetics